Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/14/2007EP1853612A1 Purification of rapamycin
11/14/2007EP1853606A1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/14/2007EP1853602A1 Chemical compounds
11/14/2007EP1853600A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853588A1 Chemical compounds
11/14/2007EP1853584A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853313A2 Humanized l243 antibodies
11/14/2007EP1853312A2 Methods and compositions for modulating tweak and fn14 activity
11/14/2007EP1853302A2 Antiangiogenic agents with aldesleukin
11/14/2007EP1853300A2 Methods of using death receptor agonists and egfr inhibitors
11/14/2007EP1853297A1 Insulin-like growth factor binding protein-4 compounds and methods for inhibiting angiogenesis and tumor growth in mammalian cells
11/14/2007EP1853277A1 Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors
11/14/2007EP1853274A2 2-methylene-19-nor- (20s-24s) - 1alpha, 25-d hydroxyvitamine-d2
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853250A1 Combinations and modes of administration of therapeutic agents and combination therapy
11/14/2007EP1853245A2 Formulations of suberoylanilide hydroxamic acid and methods for producing same
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1545709B1 Neoadjuvant treatment of breast cancer
11/14/2007EP1539756B1 Imidazopyridines as cyclin dependent kinase inhibitors
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1409480B1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
11/14/2007EP1409021B1 Formulation comprising fulvestrant
11/14/2007EP1362053B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1339433B1 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
11/14/2007EP1309860B1 Method for screening peptides for use in immunotherapy
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1244435B1 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0952843B1 Pharmaceutical formulations for sustained drug delivery
11/14/2007CN101072875A Novel cancer antigen peptide and the use thereof
11/14/2007CN101072797A Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/14/2007CN101072793A Il-7 variants with reduced immunogenicity
11/14/2007CN101072792A Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
11/14/2007CN101072781A Macrocyclic quinazoline derivatives and their use as mtki
11/14/2007CN101072779A 2,4 (4,6) pyrimidine derivatives
11/14/2007CN101072764A (-)-epigallocatechin gallate derivatives for inhibiting proteasome
11/14/2007CN101072759A Triazole compounds that modulate hsp90 activity
11/14/2007CN101072758A 喹唑啉衍生物 Quinazoline derivatives
11/14/2007CN101072589A Conjugates with enhanced cell uptake activity
11/14/2007CN101072588A Liposomes with improved drug retention for treatment of cancer
11/14/2007CN101072556A Triazoles useful as inhibitors of protein kinases
11/14/2007CN101070538A Human epiterm growth-factor receptor mutation gene and use thereof
11/14/2007CN101070350A Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin
11/14/2007CN101070349A Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
11/14/2007CN101070342A Balsm-pear-seed ribosome inactivated protein and its coding gene and use
11/14/2007CN101070340A Hornet anti-bacterial peptide, its preparing method and use
11/14/2007CN101070339A Method for preparing Chinese-Taxillus-twig anti-liver-cancer BEL 7402 protein
11/14/2007CN101070291A N-OR amides compound, its preparing method and use
11/14/2007CN101070274A Diphenylethene compound with anti-tumor activity and preparing method
11/14/2007CN101070273A Anti-tumor compound trans-4-[2-(3,5,-dimethoxyphenyl) vinyl]-1,2-xyyl alcohol and preparing method therefor
11/14/2007CN101069743A Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases
11/14/2007CN101069735A Turmeric volatile-oil extraction and curcumin chemical compounds purifying method
11/14/2007CN101069724A Compounded medicine for treating esophagus cancer and stomach cancer and preparing method
11/14/2007CN101069719A Selenium-rich tea pigment extracting technology
11/14/2007CN101069718A Selenium-rich tea pigment capsule
11/14/2007CN101069554A Method for preparing Chinese magnoliavine fruit functional salad jam
11/14/2007CN100348615C Gene of restraining activation NF-kB and NFAT, and coded polypeptide
11/14/2007CN100348614C Idiosyncratic antigen protein, and antigen peptide of liver cancer orchis pellet
11/14/2007CN100348612C Peptide benzamide compound and its preparation method
11/14/2007CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors
11/14/2007CN100348591C Substituted methylene pyrones derivatives and their preparing process and use
11/14/2007CN100348580C Taxol enhancer compounds
11/14/2007CN100348569C Induction of apoptosis in cancer cells
11/14/2007CN100348568C Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof
11/14/2007CN100348266C Peptide antagonists of zonulin and methods for use of the same
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/14/2007CN100348209C Natural lycopene compound oil preparation and capsule and its preparing method and use
11/14/2007CN100348205C Glossy ganoderma spore oil fat emulsion
11/14/2007CN100348194C Lipid formulation of nolatrexed dihydrochloride and its preparation method
11/14/2007CN100348182C Method for extracting amino acid from earthworm body using organic substance
11/14/2007CN100348179C Prepn process of microcapsule with included anticancer medicine
11/13/2007US7294753 Method for preparing anti-MIF antibodies
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294648 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/13/2007US7294629 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294621 Lipid analogs for combating tumors
11/13/2007US7294620 Lipid analogs for inhibiting HIV-1 activity
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2283637C Upar mimicking peptide
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/13/2007CA2152137C Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
11/08/2007WO2007127965A1 Treating glaucoma, cardiovascular diseases, and renal diseases
11/08/2007WO2007127624A1 Reducing cancer cell invasion using an inhibitor of toll like receptor signaling
11/08/2007WO2007127183A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007WO2007127138A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 2211